company background image
WXIB.F logo

WuXi Biologics (Cayman) OTCPK:WXIB.F Stock Report

Last Price

US$1.74

Market Cap

US$7.2b

7D

-28.9%

1Y

-73.3%

Updated

26 Mar, 2024

Data

Company Financials +

WuXi Biologics (Cayman) Inc.

OTCPK:WXIB.F Stock Report

Market Cap: US$7.2b

WXIB.F Stock Overview

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development, and manufacturing in the People’s Republic of China, North America, Europe, and internationally.

WXIB.F fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends0/6

WuXi Biologics (Cayman) Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for WuXi Biologics (Cayman)
Historical stock prices
Current Share PriceHK$1.74
52 Week HighHK$6.60
52 Week LowHK$1.74
Beta0.66
1 Month Change-24.89%
3 Month Change-48.52%
1 Year Change-73.27%
3 Year Change-86.95%
5 Year Change-84.22%
Change since IPO-74.86%

Recent News & Updates

Recent updates

Shareholder Returns

WXIB.FUS Life SciencesUS Market
7D-28.9%-1.9%0.6%
1Y-73.3%3.9%29.5%

Return vs Industry: WXIB.F underperformed the US Life Sciences industry which returned 3.4% over the past year.

Return vs Market: WXIB.F underperformed the US Market which returned 29.8% over the past year.

Price Volatility

Is WXIB.F's price volatile compared to industry and market?
WXIB.F volatility
WXIB.F Average Weekly Movementn/a
Life Sciences Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: WXIB.F's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine WXIB.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
201412,397Chris Chenhttps://www.wuxibiologics.com

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development, and manufacturing in the People’s Republic of China, North America, Europe, and internationally. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and material supplier activities. The company has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates.

WuXi Biologics (Cayman) Inc. Fundamentals Summary

How do WuXi Biologics (Cayman)'s earnings and revenue compare to its market cap?
WXIB.F fundamental statistics
Market capUS$7.24b
Earnings (TTM)US$471.01m
Revenue (TTM)US$2.36b

15.4x

P/E Ratio

3.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
WXIB.F income statement (TTM)
RevenueCN¥17.03b
Cost of RevenueCN¥10.21b
Gross ProfitCN¥6.83b
Other ExpensesCN¥3.43b
EarningsCN¥3.40b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Mar 27, 2024

Earnings per share (EPS)0.81
Gross Margin40.08%
Net Profit Margin19.96%
Debt/Equity Ratio4.9%

How did WXIB.F perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.